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The high replication and mutation rates of RNA
viruses can result in the emergence of new epidemic
variants. Thus, the ability to follow host-specific
evolutionary trajectories of viruses is essential to
predict and prevent epidemics. By studying the
spatial and temporal evolution of chikungunya virus
during natural transmission between mosquitoes
and mammals, we have identified viral evolutionary
intermediates prior to emergence. Analysis of virus
populations at anatomical barriers revealed that the
mosquito midgut and salivary gland pose population
bottlenecks. By focusing on virus subpopulations
in the saliva of multiple mosquito strains, we recapit-
ulated the emergence of a recent epidemic strain of
chikungunya and identified E1 glycoprotein muta-
tions with potential to emerge in the future. These
mutations confer fitness advantages in mosquito
and mammalian hosts by altering virion stability
and fusogenic activity. Thus, virus evolutionary tra-
jectories can be predicted and studied in the short
term before new variants displace currently circu-
lating strains.
INTRODUCTION
A hallmark of RNA viruses is that rapid replication with high mu-
tation rates can result in the emergence of new epidemic variants
(Domingo, 2010). Unfortunately, such variants are usually identi-
fied retrospective to epidemics (Davis et al., 2005; Schuffe-
necker et al., 2006) because wide-scale monitoring of circulating706 Cell Host & Microbe 15, 706–716, June 11, 2014 ª2014 Elsevierstrains is time and labor intensive, and predicting long-term
evolution is complicated by ecological factors (Holmes, 2013;
Weaver and Barrett, 2004). Recent studies in the adaptation of
H5N1 influenza virus to droplet transmission in ferrets exem-
plifies how evolutionary experiments can shed light on the adap-
tive pathways available to RNA viruses to increase fitness in a
new host (Herfst et al., 2012; Imai et al., 2012). These studies un-
derscore the need to better target surveillance of current strains
and predict their evolution, at least in the short term, with more
confidence (Holmes, 2013). Since surveillance currently relies
on consensus sequencing, adaptive mutations are masked by
wild-type sequence and only identified once they dominate the
virus population, a process that can take months or years.
Depending on the virus under study, the likelihood of identifying
emerging variants in a circulating strain can be further hindered
by the nature of the isolate: (a) amplification and passage of pri-
mary isolates in cell culture can alter the composition of mutants
within the population; (b) pooling of samples can dilute the abun-
dance of an emerging variant; and (c) the anatomical origin of the
sample may not represent the virus population most likely to be
transmitted.
Retrospective studies attempting to experimentally recapitu-
late and mechanistically explain emergence events from previ-
ous epidemics have had some success. For example, in 2005/
2006 an epidemic of chikungunya virus that normally circulates
in Aedes aegypti mosquitoes occurred in the Indian Ocean
islands when an alanine-to-valine mutation at residue 226
of the E1 glycoprotein (A226V) promoted enhanced infectivity
of another mosquito vector, Aedes albopictus (Schuffenecker
et al., 2006; Tsetsarkin et al., 2007; Vazeille et al., 2007). Subse-
quent studies uncovering epistatic interactions of A226V with
previously acquired E2 glycoprotein mutations revealed a step-
wise evolutionary trajectory that partly explains the delay in its
emergence (Tsetsarkin et al., 2011). An ecological factor likely
impacting this emergence was the abundance of Ae. albopictusInc.
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Figure 1. Infection Kinetics and Population
Dynamics of Chikungunya Virus in Mosqui-
toes
(A–D) At indicated days after feeding on blood
meals containing 106 pfu/ml of chikungunya virus,
virus titers were assayed by qRT-PCR in (A) mid-
guts, (B) legs/wings, (C) salivary glands, and (D)
saliva from Aedes aegypti mosquitoes. Titers for
individual mosquitoes (scatter plot) and median
(bar) are shown.
(E) The mean genetic diversity present in blood
meals, midguts, legs/wings, salivary glands, and
saliva from individual mosquitoes 7 days after
infection, represented as the average number of
mutations per 104 nt sequenced. A general trend of
reduction in genetic diversity at known anatomical
barriers confirms the presence of population
bottlenecks (midgut, salivary glands). Between 70
and 96 clones and an average of 82,000 nt were
sequenced per sample; n = 6 mosquitoes; **p <
0.01 by X2 test.
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compared to endemic regions (Tsetsarkin et al., 2007). Taken
together, these conditions created an optimal environment
for the emergence of A226V, a problematic event given the
world-wide distribution of Ae. albopictus. However, although
the adaptive mutation required a single nucleotide substitution,
the emergence of this variant in nature required years to occur,
and as a result the aforementioned studies were performed after
the fact. Here, we show that emergence events that require years
to identify in nature can be more readily identified and predicted
by monitoring transmission site-specific virus subpopulations
during experimental infection and transmission in vivo.
RESULTS
Chikungunya Virus Infection Dynamics and Population
Bottlenecks
Given that higher fitness variants remain undetected until they
displace wild-type after repeated infection and spread across
hosts, we hypothesized that studying the spatial and temporal
evolution of these viruses in vivo could more quickly identify
evolutionary intermediates prior to emergence. Since mosqui-
toes are persistent carriers of arboviruses, we first optimizedCell Host & Microbe 15, 706–7experimental conditions by infecting
Ae. aegyptimosquitoes with chikungunya
virus and monitoring replication in mid-
guts (first site of replication), legs and
wings (disseminating population), salivary
glands (final site of replication), and saliva
(transmitted population) (Figures 1A–1D).
The initial infection of midguts was
followed by increasing titers of circulating
and transmitted virus that peaked 7 days
after infection. To study whether virus
populations differed upstream and down-
stream of known anatomical barriers, we
determined the relative viral genetic di-versity in compartment-specific subpopulations at peak titers.
Fluctuations in the global genetic diversity in each compartment
are in accordance with two population bottlenecks expected to
coincide with anatomical barriers in midguts and salivary glands
(Figure 1E) that were previously confirmed forWest Nile and Ven-
ezuelan equine encephalitis viruses (Ciota et al., 2012; Forrester
et al., 2012).
Emergence of the Chikungunya Virus E1 A226V Indian
Ocean Epidemic Strain in the Saliva of Mosquitoes
Infected with the Pre-epidemic Strain
To study the predictive power to identify evolutionary intermedi-
ates with this approach, we focused on the viral subpopulations
transmitted in the saliva of individualmosquitoes after the peak of
infection. We asked whether we could recapitulate the emer-
gence of the E1 A226V amino acid change responsible for the In-
dian Ocean epidemic (Schuffenecker et al., 2006; Tsetsarkin
et al., 2007; Vazeille et al., 2007). We infected both Ae. aegypti
and Ae. albopictus mosquitoes with the pre-epidemic strain
(alanine at residue 226) and deep sequenced individual mosquito
saliva samples 10days after infection (Table 1). All tenAe. aegypti
mosquitoes presented only the original strain with no detectable
changes at residue 226 (limit of detection < 0.01%). In contrast,16, June 11, 2014 ª2014 Elsevier Inc. 707
Table 1. Identification of E1 Glycoprotein Variants A226V and
V80I:A129V in Transmission Compartments of Mosquitoes of
Different Geographical Origin
Nature of Sample Mosquito No.a Mutation (%)
A226V (%)
A226 pre-epidemic stockb n/a <0.01
Ae. aegypti saliva
Nakhon Chum, Thailand
1–10 0.016–0.04
Ae. albopictus salivac
Phu Hoa, Vietnam
1 11.65
2 9.12
3 99.91
4 0.03
Ae. albopictus matched
bodiesc
Phu Hoa, Vietnam
1 0.07
2 0.09
3 0.08
4 <0.01
V80I (%) A129V (%)
A226V postepidemic stockd n/a 0.06 0.01
Ae. aegypti salivae
Rockefeller Colony
1 10.55 68.21
2 9.01 56.39
3 10.00 49.82
4 21.98 55.21
5–8 <0.01 <0.01
Ae. aegypti matched salivary
glande
Rockefeller Colony
1 0.015 0.020
2 <0.01 0.032
3 <0.01 0.021
4 0.011 0.017
5 <0.01 <0.01
6 <0.01 <0.01
7 <0.01 <0.01
8 <0.01 <0.01
Ae. aegypti saliva
Be´noue´, Cameroon
1 10.89 70.02
2 0.06 0.07
3 0.11 0.11
4 0.05 0.11
5 5.38 5.81
6 0.06 0.11
n/a 21.06 22.27
7–8 <0.01 <0.01
Ae. aegypti saliva
Paea, Tahiti
1 69.03 69.86
2 16.03 16.53
3 43.36 44.11
4–7 <0.01 <0.01
Ae. albopictus saliva
Bertoua, Cameroon
1 98.75 98.74
2 34.28 10.52
3 0.21 0.23
4 46.01 47.09
5 99.69 99.67
6 0.18 0.28
7 0.05 0.11
8–10 <0.01 <0.01
Table 1. Continued
Nature of Sample Mosquito No.a Mutation (%)
V80I (%) A129V (%)
2012 Cambodian patient
stockf
n/a <0.01 <0.01
Ae. aegypti saliva
Kampong Cham,
Cambodia
1 0.14 0.22
2 51.92 52.70
3 0.10 0.12
4 58.87 59.96
5 1.70 1.74
6 57.07 58.56
aWhen either mutation of interest could be detected above background,
the individual values are shown; the grouped mosquitoes only presented
the original strain with no detectable mutations at these sites; the limit of
detection < 0.01% is then given.
bThe pre-2005/2006 epidemic stock, presenting an alanine at position
226, used to infect mosquitoes.
cDeep sequencing of matched saliva and body samples from individual
mosquitoes.
dThe parental A226V virus stock, corresponding to the 2005/2006 Indian
Ocean epidemic strain, used to infect mosquitoes in this study.
eDeep sequencing of matched saliva and salivary gland samples from in-
dividual mosquitoes. See also Table S1.
fThe 2012 isolate obtained from a Cambodian patient used to infect
mosquitoes.
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708 Cell Host & Microbe 15, 706–716, June 11, 2014 ª2014 Elsevierwe detected the A226V mutation in three of four Ae. albopictus
mosquito saliva samples (at 9%, 11%, and 99% total virus
population). A226V was the only mutation emerging at a high
frequency in these transmission samples, confirming that our
approach could have predicted the emergence of the 2006
epidemic strain in as little as 10 days of infection in vivo. Impor-
tantly, the abundance of these mutations in saliva was consider-
ably higher than in the corresponding mosquito bodies (Table 1),
thus highlighting the biological relevance of specifically moni-
toring transmissible subpopulations.
Emergence of Chikungunya Virus E1 Variants in the
Saliva of Mosquitoes Carrying the Currently Circulating
Indian Ocean Epidemic A226V Strain
Given the success in rapidly identifying the A226V adaptation
that required years to emerge in nature, we asked whether in-
fecting mosquitoes with the post-2005/2006 epidemic strain
could identify future emergence events. Ae. aegypti and albopic-
tus mosquitoes (established lab colonies and recently captured
from African and Asian locations) were infected for 10 days
with the A226V strain, and saliva samples were deep sequenced
in the E1 glycoprotein gene. In all four experiments, two muta-
tions (V80I and A129V) were the only mutations to amplify to
significantly high frequency in the saliva of multiple mosquitoes
(Tables 1 and S1). Since saliva is a cell-free environment, replica-
tion of these variants would have expectedly occurred in salivary
glands. Indeed, mosquitoes with high frequencies of V80I and
A129V in saliva presented thesemutations at low, yet significant,
frequency in salivary glands, whereas no mutations could be de-
tected in the glands of saliva-negative mosquitoes (Table 1).
Furthermore, molecular cloning and Sanger sequencing of 70–
96 genomes per population confirmed that these mutations,Inc.
A
9
2
3
4
5
6
7
8
1
P P-DM P P-DM P P-DM P P-DM P P-DM P P-DM
ydoBydoB Legs Saliva Legs Saliva
Ae. aegypti Ae. albopictus
B
Lo
g 1
0 
R
N
A 
ge
no
m
es
/m
l
Lo
g 1
0 
R
N
A 
ge
no
m
es
/m
l 9
2
3
4
5
6
8
1
7
P P-DM P P-DM P P-DM
Body Legs Saliva
P=0.0011
P=0.016 P=0.0001 P=0.0001
ns
ns
ns
ns
P=0.053
Figure 2. The P-DM Strain Presents an
Increased Replication Advantage in Mos-
quito Hosts
(A) High-dose infection (106 pfu/ml) of Ae. aegypti
and Ae. albopictus mosquitoes with the parental
A226V strain (P) or with the additional two muta-
tions V80I:A129V (P-DM). Virus titers were deter-
mined 7 days after infection in bodies, legs/wings,
and saliva by qRT-PCR. Significant p values are
indicated. ns, no significant difference observed
between P and P-DM (p > 0.5); n = 30; two-tailed
unpaired Student’s t test; box plots show median
value and minimum and maximum values.
(B) Low-dose infection (103pfu/ml) ofAe.albopictus
mosquitoes. Significant p values are indicated. ns,
no significant difference (p > 0.5); n = 20; two-tailed
unpaired Student’s t test; box plots show median
value and minimum and maximum values.
Cell Host & Microbe
In Vivo Evolution of Emerging Virus Strainswhen present at equal frequencies, were always linked on the
same genome (data not shown).
Emergence of V80I:A129V in Cambodian Mosquitoes
Infected with a Currently Circulating A226V Isolate from
a Cambodian Patient
Since the infectious clone used in the lab was derived from a
2006 A226V isolate obtained from a patient in La Re´union Island,
we investigated whether similar emergence events can occur
in more recent circulating strains. We infected Cambodian
Ae. aegypti mosquitoes that were recently caught in the wild (F2
generation) with a recent 2012 isolate from a Cambodian patient.
After 10 days of infection, the V80I:A129V mutations were once
more the only mutations to be identified in the saliva of all six
mosquitoes (Table 1), providing further evidence that these muta-
tions are evolutionary intermediates of currently circulating strains.
Chikungunya Virus V80I:A129V Mutations Confer
Replication Advantages to the A226V Strain in
Mosquitoes
We explored whether the V80I and A129V mutations incur
an advantage in vivo or whether they represent ‘‘transmission
dead ends’’ with no biologically relevant advantage. Starting
from the parental A226V infectious clone (P), we engineered
the double-mutation V80I:A129V (P-DM) and compared the
strains in terms of infection (bodies), dissemination (legs and
wings), and transmission (saliva) in both mosquito hosts. At
high-infection doses (106 plaque-forming units [pfu]/ml), P-DM
strain presented the same titers as the parental strain in
Ae. aegypti and significantly higher infection (p = 0.0011) and
dissemination (p = 0.016) titers in Ae. albopictus (Figure 2A).
Since mosquitoes in nature are exposed to a wide range of
viremic titers in mammalian hosts, we repeated the Ae. albopic-
tus infection using lower doses (103 pfu/ml). At a low dose, the
P-DM strain presented more significant infection (p = 0.0001),
dissemination (p = 0.0001), and transmission (p = 0.053) titers
(Figure 2B). Since the E1 mutations arose in both mosquito spe-
cies (Table 1), yet a benefit was only observed in Ae. albopictus,
we sequenced a high and low titer saliva sample from the A226V-
infected Ae. aegyptimosquitoes characterized in Figure 2A. The
high titer ‘‘parental’’ sample had in fact already evolved into the
P-DM genotype by the time the sample was taken, indicatingCell Hthat the relatively equal fitness observed for P-DM in this species
may be underestimated in our experiment.
P-DM Strain Leads to Increased Viral Loads and
Pathogenesis in a Mammalian Infection Model
To examine the impact of the V80I:A129V mutations in the
mammalian host, we infected a small rodent infection model
(8-day-old mice) (Couderc et al., 2008) with lethal doses (106
pfu) of parental virus compared to the P-DM strain and moni-
tored survival (Figure 3A). Since chikungunya virus is not gener-
ally fatal in humans (Manimunda et al., 2011; Renault et al., 2008),
this model is not representative of CHIKV pathogenesis; rather,
virulence and tropism in these mice is a close surrogate for repli-
cative capacity in mammals (Couderc et al., 2008; Ozden et al.,
2007; Ziegler et al., 2008). Infection of newborn mice resulted in
40% mortality by 14 days of infection with parental virus and
100% mortality by 6 days of infection with P-DM. As expected,
adult mice showed no signs of virulence with either strain (Fig-
ure 3A). To confirm this presumed increase in replicative capac-
ity, we administered a sublethal dose (102 pfu) to 8-day-old mice
and titrated virus in different organs. Virus titers were signifi-
cantly higher (up to 100-fold) for the new strain in both blood
and muscle (Figure 3B).
The V80I:A129V Mutations Alter Fusion Activity and
Particle Stability In Vitro
To address themolecular mechanisms underlying the fitness ad-
vantages observed in vivo, we compared tissue culture pheno-
types of the P-DM strain, as well as each individual mutation
(P-V80I and P-A129V), to the parental A226V virus. We did not
observe significant advantages or defects for most traits relating
to the virus life cycle under the standard cell culture conditions
(receptor binding, entry via endocytic pathways, RNA synthesis,
and E1 glycoprotein expression; Figure S1). Electron micro-
scopy of infected mosquito and human cells revealed no differ-
ences in cell and virus morphology or budding (Figure S2). We
thus compared the production of infectious virus in a larger panel
of cell lines. The yield of the P-DM strain was similar to parental
virus in most cell lines assayed and significantly higher in one
murine and two human lines (Figure 4A), in accordance with
the increased replication observed in the mouse model (Fig-
ure 3B). Based on the crystal structure of the E1 glycoprotein,ost & Microbe 15, 706–716, June 11, 2014 ª2014 Elsevier Inc. 709
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Figure 3. The P-DM Strain Presents
Increased Viral Loads and Pathogenesis in
a Mammalian Host
(A) Survival of 8-day-old (solid lines) or 3-week-old
(dashed lines) C57BL/6 mice inoculated with 106
pfu of the parental strain (solid circle) or P-DM
(open circle). p < 0.0001; n = 12; log-rank Mantel-
Cox test.
(B) Tissue-specific virus titers 7 days after suble-
thal infection (200 pfu) of mice infected with
parental strain (P) or P-DM. p values are shown; ns,
no significant difference observed between P and
P-DM (p > 0.5); n = 4–6 mice per day; two-tailed
unpaired t test.
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of residues 80 and 129 on function. Slow and fast mode analysis
suggested an implication in conformational changes during
fusion and/or in structural stability of the virion (Figures 4B and
S3). To address the fusion activity of each virus in detail, we per-
formed fusion from without assays using a GFP-expressing
parental (P-GFP), individual (P-V80I-GFP and P-A129V-GFP),
and double mutation (P-DM-GFP) containing viruses on baby
hamster kidney (BHK) and mouse embryonic fibroblast (MEF)
cells using a range of pH from 5.0 to 7.4. Fusion activity was
similar for all viruses over this range, but P-DM-GFP virus had
significantly higher fusion at the most relevant pH range (pH
5.4–5.8) (Figures 4C and 4D). The A129V single mutation also
showed trends in increased fusion that were significant in one
instance (Figure 4C). In addition, we treated GFP-expressing
viral stocks with the same panel of pH buffers to ‘‘pre-trigger’’
a conformational change in the E1 glycoprotein prior to infection.
As in the cellular fusion assay, fusion was triggered at signifi-
cantly higher levels (thus, lower residual infectivity following pre-
treatment) for P-DM-GFP at several pH values, and both single
mutations more readily fused at pH 5.8 compared to the parental
strain (Figure 4E). Finally, fusion activity was examined in the
presence of four different fusion-blocking antibodies. In three
of four cases, the P-DM strain retained a more significant level
of fusion activity (Figure 4F). To address particle stability, we
incubated viruses in cell-free suspension at 28C (mosquito tem-
perature) and at 37C (mammalian temperature) (Figure 4G). The
single mutants P-V80I, P-A129V, and the P-DM strain presented
increased stability at both temperatures, notably retaining up to
95% of their specific infectivity after 48 hr at mosquito tempera-
ture compared to 10% of parental virus.
Emergence and Dominance of the P-DM Strain during
Natural Transmission
Since the V80I:A129V mutations were found to have significant
fitness advantages in vitro and in vivo in both mosquito and
mammalian hosts, we addressed the evolution of the parental
A226V strain in the most natural experimental setting possible.
To do so, we established an infection and transmission model
(Figure 5A) where individual African Aedes aegypti mosquitoes
were infected with the parental strain and fed on individual
mice, which in turn were fed to a second batch of mosquitoes.
At each transmission step, individual bodies and saliva of
mosquitoes and blood of mice were deep sequenced. Following
the first transmission of 18 infected mosquitoes to mice (Fig-710 Cell Host & Microbe 15, 706–716, June 11, 2014 ª2014 Elsevierure 5B), six mice failed to present virus in blood and could not
transmit to the second batch of mosquitoes, and one mouse
succumbed to infection before this second transmission step.
For the remaining 11 infected mice, each further transmitted vi-
rus to at least two naive mosquitoes (every engorged mosquito
that fed on mice became positive for CHIKV by 10 days post-
feeding). Deep sequencing of the saliva populations of eight of
the initially infected mosquitoes (series #1–8) revealed the emer-
gence of the P-DM strain at frequencies ranging from 0.25% to
99.68% (Figure 5B).When present in saliva, this strain was trans-
mitted to mice, where its frequency fluctuated without an
apparent positive or negative trend yet remained the most abun-
dant minority genotype in the blood (Figure 5B). Of the 24 naive
mosquitoes that fed on these mice during the second transmis-
sion step (series #1–8), 18 presented P-DM at very high fre-
quency in their bodies, which was further amplified in saliva to
displace the parental A226V strain. For mice that did not present
V80I and A129V in the blood (#10–12), only the original A226V
strain was transmitted to naive mosquitoes, yet four of these
mosquitoes also developed the P-DM variant in saliva de novo,
similar to the initial infection of the first batch of mosquitoes.
We analyzed the dynamics of these variants in different compart-
ments (Figure 5C) and identified two potential events of positive
selection (Figure S4). One was revealed by a positive correlation
between the presence of P-DM in the blood of mice and its
amplification in the bodies of mosquitoes feeding upon them
(p = 0.037), while the other was revealed by a correlation be-
tween the P-DM frequencies in mosquito bodies compared to
saliva in both mosquito batches (p = 0.012 and 0.004). Similar
results were obtained in a second experiment using Asian
Ae. aegypti mosquitoes (Figure S5). In summary, the data indi-
cate that the P-DM strain is a genotype capable of emerging
and displacing the parental A226V epidemic strain during natural
transmission from mosquitoes to mammals.
DISCUSSION
In this study, we developed an experimental approach tomonitor
the selection and emergence of a strain of chikungunya that
proved to be epidemic (A226V) aswell as the continued evolution
of this strain to contain two E1 mutations (V80I and A129V).
Importantly, these mutations were the only ones to arise
above the 0.01%–0.2% frequency range that encompassed
the remainder of minority variants in the viral populations inmulti-
ple mosquitoes of both African and Asian origin (Table S1).Inc.
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the mosquito body (e.g., midgut, salivary gland), they were en-
riched to high frequencies in the saliva compartment. We attri-
bute the success of this approach to several improvements
over the more conventional protocols in studying, and trying to
predict, virus evolution and emergence. First, mosquitoes are
rarely sampled beyond the day that peak titers are reached (for
chikungunya, 7 days), which may not be sufficient time for adap-
tive mutations to be generated and amplified. Indeed, the muta-
tions described here could not be detected during the first 5 days
of infection (data not shown). Moreover, pooling of samples
would have diluted the high frequency variants present in a few
mosquitoes to the limit of detection. Even within individual
mosquitoes, the highest-frequency variants present in saliva
would have been lost in the background of the body and salivary
gland populations, where titers can be over three orders of
magnitude higher. Finally, without deep sequencing, emerging
mutations would not have been detected in enough individuals
to differentiate them from stochastic mutations occurring within
each mosquito. Our results have significant implications for cur-
rent surveillance strategies during and between epidemics. The
fact that the A226V mutation was the only one to occur at high
frequency in multiple Ae. albopictus mosquitoes could have
alerted us to a potential emergence event well before it took
hold in nature. That A226V arose to high frequencies in mosqui-
toes in only 10 days, while it took several years to emerge in na-
ture, suggests that ecological factors play the final decisive role
on which variants emerge, following selection within the host.
The natural transmission studies presented here suggest that
selection of the P-DM strain occurs in two different stages of the
infection cycle (Figure S4). The high frequencies of these muta-
tions in saliva compared to salivary glands suggest a selective
step after virus replication and egress into a cell-free environ-
ment. As suggested by molecular modeling and confirmed by
in vitro stability studies, the P-DM variant retains infectivity for
periods significantly longer than those of parental A226V in
cell-free conditions. Thus, although both strains have similar
replication kinetics and yields, the superior survival of
V80I:A129V-containing virion outside of host cells (particularly
at mosquito temperatures) could account for their temporal in-
crease in abundance in saliva samples. If this increased stability
and specific infectivity confers a similar advantage during
extracellular stages in the host (e.g., circulating in the hemocoel
of mosquitoes or bloodstream of mammals), this effect may
partially account for the increased titers of virus observed
in mosquito and mouse tissues. However, since molecular
modeling, fusion assays, and infections in the presence of
fusion-blocking antibodies also showed that P-DM is better
able to enter cells under more stringent conditions, increased fu-
sogenic activity may play the more significant role during selec-
tion in mosquito bodies, before egress into saliva. Increased
fusion may also account for the higher fitness of P-DM observed
in some human and murine cell lines. Positive selection for mu-
tations V80I and A129V is thus a combination of improved stabil-
ity and fusogenic activity, as evidenced by the predominance
and further implication of this strain in bodies and saliva of
mosquitoes feeding on mice that have P-DM in their blood.
Normal mode analysis suggests that these residues may be
part of an epistatic network that includes position 226, whichCell Hmay explain why these mutations were observed in every exper-
iment using A226V, but not in the mosquitoes infected with the
pre-epidemic A226 strain. Further work is required to determine
whether the V80I and A129V mutations would confer fitness ad-
vantages to strains carrying alanine at position 226.
Whether these mutations will emerge in nature will depend on
many ecological factors, including abundance, feeding habits
and average life-span of infected mosquitoes, the mosquito
species carrying the virus in sylvatic or urban settings, and pre-
existing immunity to the previous A226V strain in the human pop-
ulation (Coffey et al., 2013; Kilpatrick, 2011; Kilpatrick et al.,
2006; Kuno and Chang, 2005; Le Flohic et al., 2013). Neverthe-
less, we showed the emergence of these variants in single mos-
quito infections in both primary mosquito vectors at a rate similar
to that of the A226V epidemic strain. Fitness was more markedly
increased in Ae. albopictus, the vector with a larger and expand-
ing world distribution (Lambrechts et al., 2010). Furthermore,
fitness was significantly increased in the small rodent model
and in some human cell lines. These in vitro and in vivo pheno-
types suggest that these mutations should at least be monitored
over the years to come. In any case, such studies identify vari-
ants of biological significance that can help us better understand
virus protein function and viral pathogenesis.
Finally, the conducted study focused on the E1 glycoprotein,
which was previously implicated in the emergence of chikungu-
nya epidemic variants. It will be interesting to further expand
these studies to whole-genome sequencing of other circulating
strain/mosquito combinations, since a number of new E2 glyco-
protein mutations have been identified in recent Indian strains
(Tsetsarkin and Weaver, 2011). Our approach is equally relevant
to other arboviruses of clinical interest, such as dengue virus
and West Nile virus. From a wider perspective of clinical and
experimental host-pathogen studies, our results underscore
the importance of monitoring virus evolution in specific subpop-
ulations in vivo (e.g., salivary, fecal, seminal, and respiratory
transmission samples), which may be missed at other sites.
These studies provide an initial framework to understanding
the temporal and spatial evolutionary trajectories of viruses as
they disseminate through their host. We hope that such efforts
could generate short lists of evolutionary intermediates most
likely to emerge from a current strain to better target surveillance
and ideally predict future emergence events in order to improve
preparedness and response.EXPERIMENTAL PROCEDURES
Cell and Viruses
Mammalian (BHK-21, Vero, and HeLa) cells were maintained in GlutaMAX
Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 10%
newborn calf serum (NCS) (Gibco) and 1% penicillin and streptomycin (P/S)
(Sigma-Aldrich) at 37C with 5% CO2. Human embryonic kidney 293T
(HEK293T), NIH 3T3, Nor-10, A549, and BEAS-2B cells were maintained in
DMEM supplemented with 10% fetal bovine serum (FBS) and 1% P/S. Aedes
albopictus cells (C6/36 and U4.4) and Aedes aegypti cells (Aag-2) were main-
tained in L-15 Leibovitz medium supplemented with 10% FBS, 1% tryptose
phosphate broth, 1% nonessential amino acids, and 1% P/S at 28C. All cells
were obtained from American Type Culture Collection (ATCC) and confirmed
free of mycoplasma.
The viruses generated by reverse genetics were built on the infectious clone
(Coffey and Vignuzzi, 2011) corresponding to chikungunya virus strain 06-049
(AM258994). The 2012 Cambodian patient isolate was obtained afterost & Microbe 15, 706–716, June 11, 2014 ª2014 Elsevier Inc. 711
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Figure 4. Molecular Modeling and In Vitro Studies Point to Increased Stability and Altered Fusogenic Activity of the P-DM Strain
(A) Progeny virus titers following infection of a panel of mammalian and mosquito cell lines with the parental A226V (open bars) or P-DM strain (solid bars). Mean
values and SEM are shown. p values are indicated when significant; otherwise, differences between strains are not significant; n = 3; two-tailed unpaired t test.
(B) GNM analysis of the E1 structure taken from the E1-E2 complex (PDB ID code: 2FXB) (Voss et al., 2010). Position 80 could be important for E1 structural
stability or protein-protein interactions. Residue 80 (red) is in a cluster of the highest-frequency fluctuating residues (60, 64, 66, 80, 81, and 100–102; encircled and
shown in atom spheres model). The cluster includes amino acids 64 and 66 (yellow) of the bc loop (cyan), which participates in E1 trimer-trimer interactions. Other
structural elements of functional importance in the vicinity include the fusion (83–98, green), IJ (218–235, blue) loops, and position 226 (red). Amino acid 129 (red)
is right near the main hinge of the protein (encircled); mutations in this position could affect E1’s flexibility. The slowest mode of motion of E1 divides the structure
(legend continued on next page)
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In Vivo Evolution of Emerging Virus Strainsinoculation of a patient serum into C6/36 cells. Both stocks contain the A226V
mutation that emerged during the 2005/2006 Indian Ocean outbreak. Infec-
tious virus was produced by electroporating BHK cells with in vitro transcribed
viral RNAs.
Virus Titrations and qRT-PCR
Virus titrations were determined by standard plaque assay on Vero cells. The
limit of detection was 2.9 log10 pfu/ml. Viral RNA was isolated using TRIzol
(Sigma-Aldrich) and measured with quantitative RT-PCR (qRT-PCR) using
the Taqman RNA-to-CT One-Step Quantitative RT-PCR kit (Applied Bio-
systems) as previously described (Coffey and Vignuzzi, 2011). BHK, C6/36,
HEK293T, NIH 3T3, Nor-10, A549, and BEAS-2B cells were infected with
each virus at a multiplicity of infection (moi) of 1. U4.4 and Aag2 cells were
infected at moi = 10. Viral titers were determined by plaque assay.
Virus Binding Assays
BHK and C6/36 cells were incubated with CHIKV (moi = 5) at 4C for the indi-
cated times. At each time point, virus inoculum was removed, cells were
washed three times with ice-cold PBS, and 500 ml of TRIzol was added for viral
RNA extractions and qRT-PCR.
Lysosomotropic Agent Treatment
BHK andC6/36 cells were infectedwith virus at anmoi of 5 in media containing
Bafilomycin A1 for 16 hr. Following treatment, cells were fixed in 1% parafor-
maldehyde, and the number of GFP-expressing cells was quantified by flow
cytometry.
Fusion from without Assay
BHK andMEF cells were preincubated in binding buffer at 4C for 1 hr and then
added to cells at an moi of 5 for 1 hr at 4C. Unbound virus was removed and
viral fusion was induced by adding prewarmed fusion buffer (RPMI, 10 mM
HEPES, 2% BSA), adjusted to each pH described, for 2 min at 37C. The pH
was neutralized by the addition of complete media containing 20 mM NH4Cl,
and fusion was analyzed by flow cytometry.
Virus ‘‘Pretriggering’’ Assay
GFP-expressing viruseswere preincubated in fusion buffer and adjusted to the
indicated pH for 1 hr at 37C. The pH was neutralized by the addition DMEM,
and viral infectivity was measured by flow cytometry.
Virion Stability
Virus stocks were diluted to 105 pfu/ml in culture medium and incubated at
28C or 37C. At 0, 8, 24, and 48 hr, 100 ml aliquots were taken for titration
of infectivity by plaque assay and for quantification of virus particles containing
genomes by qRT-PCR. The specific infectivity was determined by dividing the
infectious virus pfu values by the total number of genomes contained in the
viral particles.into two dynamic domains (gray and pale yellow), connected by a hinge region (res
Figure S3.
(C and D) After binding of GFP viruses onto cells, BHK cells (C) or MEFs (D) w
neutralized, and the amount of GFP-expressing cells was determined after 16 hr o
included in figure). Histograms are presented in the following order: parental P-GF
GFP double mutation. The mean and SEM are shown; n = 3; *p < 0.05, **p < 0.0
(E) GFP viruseswere pretreated for 1 hr in cell-free fusion buffer at a range of pH to
infecting BHK cells and measuring the percentage of GFP-positive cells. Histog
singlemutation, P-A129V-GFP singlemutation, and P-DM-GFP doublemutation.
ANOVA.
(F) After binding to a monolayer of Vero cells, the parental (circle) or P-DM (square
Ab152, Ab166, and Ab263, and the ability to fuse was determined by measuring t
controls. n = 4; mean and SEM are shown; p values are indicated; two-tailed pa
(G) Stability of viruses in cell-free environment at 28Cor 37C. The parental (P), sin
for 8, 24, and 48 hr in solution, and the residual specific infectivity was determined
shown for the variant that was closest to P strain in value; two-tailed paired t tes
Cell HFusion-Blocking Antibody Dynamics
Antibodies CHIK102, CHIK152, CHIK166, and CHIK263 were a kind gift from
Michael Diamond (Pal et al., 2013). A total of 50 pfu of each viruswas incubated
at 4C for 1 hr on a monolayer of Vero cells, and blocking antibodies were
added for 1 hr at 4C. To induce fusion, cells were incubated at 37C for
15 min followed by the addition of an agarose overlay. Antibody inhibition
was addressed 72 hr later.
Normal Mode Analysis
Normal mode analysis of E1 and the E1/E2 dimer was conducted using the
Gaussian network model (GNM) (Emekli et al., 2008; Haliloglu et al., 1997)
and the X-ray crystal structure of chikungunya virus particles E1-E2 (Protein
Data Bank [PDB] ID code 2XFB) (Voss et al., 2010), where E1 is in complex
with E2. GNM describes the protein structure as elastic network, in which
the a carbon atoms within a cutoff radius are assumed to be connected by
Hookean springs, displaying Gausssian fluctuations around their mean posi-
tions. The correlation between two nodes i and j, DRi and DRj, respectively,
are calculated as <DRiDRj> = (3kBT/g)[G
-1]ij = (3kBT/g)
P
k[lk
-1ukuk
T]ij, where G
is an N 3 N Kirchhoff matrix of the internode contacts with the (commonly
used) cutoff of 10 A˚, where N is the number of amino acids in the protein. uk
and lk are the k-th eigenvectors and eigenvalues ofG, kB is the Boltzmann con-
stant, T is the absolute temperature, and g is a uniform force constant; kBT/g
was taken as 1 A˚2. Overall, this equation predicts the mean-square displace-
ment of each residuewhen i = j and the correlations between the fluctuations of
residues i and jwhen is j, and when is j, it predicts the correlations between
the fluctuations of residues i and j as a superimposition of N-1 eigenmodes
from the slowest to fastest modes of motion. Slow modes refer to cooperative
and global motions, whereas fast modes refer to the residues displaying local-
ized fast fluctuations. The results of the analysis of E1 alone and the E1/E2
complex are presented in Figures 4B and S3, respectively.
Mosquito Infections and Harvests
Aedes aegypti (1 lab-reared Rockefeller colony, 1 colony, F10 generation,
collected in Be´noue´, Cameroon in September 2007; 1 colony, F2 genera-
tions collected in Nakhon Chum, Thailand in 2011; 1 colony, F3 generations,
collected in Kampong Cham, Cambodia) and Aedes albopictus (1 colony,
F14 generation, collected in Bertoua, Cameroon in September 2007; 1 colony,
F2 generations, collected in Phu Hoa, Vietnam in 2011) were used for mosquito
infections. Viruses were diluted to 103 or 105 pfu/ml and mixed 1:2 with pre-
washed rabbit blood. Female mosquitoes were allowed to feed on 37C blood
meals through a chicken skin membrane for 20–60 min, after which engorged
females were incubated at 28C with 10% sucrose ad libitum; females that
did not feed were excluded. Matched titers of blood meals (within 0.3 log10
pfu/ml) were verified by titrations of blood meals immediately after feeds. After
incubations, legs and wings were removed, and the proboscis of each mos-
quito was inserted into a capillary tube containing 5 ml FBS for 45min. Midguts,
legs/wings, and salivary glands were dissected in PBS under 103 magnifica-
tion. Saliva samples in FBS were added to 45 ml of L-15 media, and the legs/
wings, bodies, and salivary glands were placed in 2 ml round bottom tubesidues 38, 128, 170, 256–259, and 267; magenta atom spheresmodel). See also
ere treated with fusion buffer at a range of pH values (5.0–7.4). pH was then
f infection. No significant differences were observed at pH values above 6.0 (not
P virus, P-V80I-GFP singlemutation, P-A129V-GFP singlemutation, and P-DM-
1, ***p < 0.005; two-way ANOVA.
trigger fusion, and viruses for which fusion was not triggered were quantified by
rams are presented in the following order: parental P-GFP virus, P-V80I-GFP
Themean and SEMare shown; n = 3; *p < 0.05, **p < 0.01, ***p < 0.005; two-way
) strains were treated with serial dilutions of fusion-blocking antibodies, Ab102,
he percentage of virus retaining infectivity on Vero cells compared to untreated
ired t test.
gle mutants P-V80I and P-A129V, or double-mutant P-DM virus was incubated
by plaque assay and qRT-PCR (n = 3; mean and SEM are shown; p values are
t).
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In Vivo Evolution of Emerging Virus Strainscontaining 300 ml DMEMand a steel ball. Sampleswere ground in aMM300 ho-
mogenizer (Retsch) at 30 shakes/s for 2 min. For infectivity determinations,
whole bodies were ground individually, using the same homogenization
methods. At least 20 mosquitoes were used per sample to ensure that enough
mosquitoes fed and became positively infected for downstream analysis.
Mouse Infections
Mice were kept in the Pasteur Institute animal facilities in BSL-3 isolators, with
water and food supplied ad libitum, handled in accordance with institutional
guidelines for animal welfare, and at endpoint they were humanely euthanized
complying with the Animal Committee regulations of Institut Pasteur in Paris,
France, in accordance with the EC 86/609/CEE directive. C57B/6 mice
(8 days old) were injected subcutaneously in the back with 200 pfu of virus,
and at selected times postinoculation, animals were sacrificed and blood
and organs were harvested. Organs were placed individually in tubes and
homogenized as for mosquitoes. Survival curves were generated by injecting
8-day- or 3-week-old female mice with 106 pfu of virus and monitoring
morbidity and mortality for 14 days after infection.
Transmission Studies
Transmission experiments were conducted at the Institut Pasteur in
Cambodia in Phnom Penh in BSL3 facilities. Briefly, mosquitoes were infected
as described previously and incubated at 28C for 10 days. On day 10, individ-
ual mosquitoes were allowed to feed on individual 5-day-old Swiss mice until
engorged. Swiss mice (5 days old) were immobilized on a mesh surface
suspended over a cup containing an individual mosquito at 28C. Mice and
mosquitoes were incubated together for 1 hr or until feeding had occurred.
Following feeding, mice were returned to cages, and individual mosquitoes
were salivated and their bodies crushed and harvested. Mice were monitored
for disease for 5 days. After 5 days of infection in mice, naive mosquitoes were
allowed to feed on individual infected mice until engorged. Following feeding,
mice were sacrificed and blood was harvested. These mosquitoes were
then incubated at 28C for ten days, salivated and their bodies crushed and
harvested. Amplicons for deep sequencing were prepared immediately after
harvesting in vivo samples, which improved the overall yield compared to
using frozen samples.
High-Throughput Sanger Sequencing and Genetic Diversity
For genetic diversity and bottleneck experiments, amplicons flanking the par-
tial E1 gene were generated using the Titan one-step RT-PCR kit (Roche) and
primers flanking genome positions 9,943–10,746. Amplicons were cloned into
TOPO vectors (Invitrogen) and sequenced using Sanger technology in 96-well
format (GATC Biotech). Mutation frequencies were determined by dividing the
number of nucleotide polymorphisms in all clones (where polymorphisms at
the same genetic locus on multiple clones were counted once) by the number
of nucleotides sequenced. Values were then represented as the number of
mutations per 104 nt sequenced.
Deep Sequencing of Samples
Viral RNAs were isolated from samples by TRIzol extraction, and the E1
gene was amplified using the Titan one-step RT-PCR kit (Roche) withFigure 5. Emergence of V80I:A129V E1 Glycoprotein Variants during In
(A) Mosquitoes were fed blood meals containing the parental A226V strain (d0), a
were then separated and allowed to feed on individual naive mice, after which t
infected mosquitoes were incubated for 5 days (d15), upon which time new batch
was then harvested for deep sequencing. The infection of the second set of mosq
saliva were harvested for deep sequencing.
(B) Deep sequencing analysis of individual mosquito body, saliva, and mouse
multiple mosquitoes transmission series for the 12 mosquitoes initially infected w
bubbles indicate the percentage of the V80I:A129Vmutations in each virus subpop
linked on the same genomes by Sanger sequencing of plaque-purified virus. The
medium shading represents >1.0%; dark shading represents >50%. ND, virus con
for deep sequencing. Dead, mouse succumbed to infection before transmission
(C) Dynamics of V80I:A129V mutation frequency during transmission. Arrows rep
subpopulation) for each matched body/ saliva/ blood/ body/ saliva tran
two-tailed correlation coefficient and permutation test.
Cell Hthe primers E1Forward(9943) 50-TACGAACACGTAACAGTGATCC-30 and
E1Reverse(10726) 50-CGCTCTTACCGGGTTTGTTG-30 following manufac-
turer’s instructions. PCR fragments were purified via the NucleoSpin Gel and
PCR Clean-up kit (Macherey-Nagel), and total DNA was quantified by Nano-
Drop. PCR products were then fragmented (Fragmentase), linked to Illumina
multiplex adapters, clusterized, and sequenced with Illumina cBot and GAIIX
technology. Sequences were demultiplexed using Illumina’s CASAVA soft-
ware, allowing for no mismatches in the multiplex tag sequences. Quality
filtering (95%–98% of reads passed) and adaptor cleaning were done using
fastq-clipper (http://hannonlab.cshl.edu/fastx_toolkit/index.html). The 75 nt
reads were aligned to the E1 sequence as a reference, with a maximum two
mismatches per read using BWA (Li and Durbin, 2009). Alignments were pro-
cessed using SAMTOOLS (Li et al., 2009) to obtain the nucleotide/base calling
at each position. An in-house ViVAn (virus variance analysis) pipeline was used
to identify statistically significant variants above the background noise due to
sequencing error calculated for each nucleotide site. Briefly, for each position
throughout the viral genome, base identity and their quality scores were gath-
ered. Each variant allele’s rate was initially modified according to its covering
read qualities based on a maximum likelihood estimation and tested for signif-
icance using a generalized likelihood-ratio test. Additionally, an allele confi-
dence interval was calculated for each allele. In order to correct for multiple
testing, a Benjamini-Hochberg false discovery rate of 5%was set. In all exper-
iments, a minimum coverage of 25,000 reads was obtained, and the back-
ground error at every nucleotide site was always below 0.01%.
Statistical Analyses
No samples or infected animals were excluded from analysis. Animals were
randomly allocated to groups before infections were performed. No blinding
was performed during experimentation and analysis. All statistical tests
(described in each figure legend) were conducted using GraphPad Prism soft-
ware. p values > 0.05 were considered nonsignificant (ns).
SUPPLEMENTAL INFORMATION
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dx.doi.org/10.1016/j.chom.2014.05.008.
ACKNOWLEDGMENTS
This work was supported by the European Research Council (ERC Starting
Grant No. 242719), by the Bill and Melinda Gates Foundation Grand Chal-
lenges Exploration Initiative, the French Government’s Investissement
d’Avenir program, Laboratoire d’Excellence ‘‘Integrative Biology of Emerging
Infectious Diseases’’ (grant ANR-10-LABX-62-IBEID), and the Israel-France
High Council for Science and Technology Research ‘‘Complexity in Biology’’
program. Salary for L.L.C. and K.A.S. was provided by the Region of Ile-de-
France DIM program on Infectious, Parasitic or Nosocomial Emerging Dis-
eases and the Philippe Foundation. Salary for A.V.B. was supported by the
French National grant ANR-09-JCJC-0118-1. Salary for C.A.-G. was sup-
ported by the French Ministry of Superior Education and Research. N.B.-T.sect-Mammal-Insect Transmission
nd infection was allowed to proceed for 10 days (d10). Individual mosquitoes
heir saliva and bodies were harvested for deep sequencing. Mice exposed to
es of several mosquitoes were allowed to feed on individual mice. Mouse blood
uitoes was incubated for another 10 days (d25), at which point their bodies and
blood samples. The bubble diagrams illustrate each mosquito-to-mouse-to-
ith A226V strain that successfully transmitted to mice. The numbers within the
ulation. Both variants were present at the same frequency and confirmed to be
background limit of detection was <0.01%; light shading represents >0.2%;
firmed present, but not determined due to inability to obtain suitable amplicons
was performed. See also Figure S5.
resent the increase or decrease of variant frequency (percentage of total virus
smission series in (A). The correlation, r, and p values are shown; Spearman’s
ost & Microbe 15, 706–716, June 11, 2014 ª2014 Elsevier Inc. 715
Cell Host & Microbe
In Vivo Evolution of Emerging Virus Strainsand T.H. were supported by NATO traveling grant CBP.MD.CLG 984340. We
are grateful to Ngan Chantha, Huy Rekol, and the team of the National Malaria
Centre in Cambodia for providing clinical specimens. We thank Christophe
Paupy (IRD), Louis Lambrechts, and Paul Reiter (IP) for providing some mos-
quito strains.
Received: December 19, 2013
Revised: March 19, 2014
Accepted: April 22, 2014
Published: June 11, 2014
REFERENCES
Ciota, A.T., Ehrbar, D.J., Van Slyke, G.A., Payne, A.F., Willsey, G.G., Viscio,
R.E., and Kramer, L.D. (2012). Quantification of intrahost bottlenecks of
West Nile virus in Culex pipiens mosquitoes using an artificial mutant swarm.
Infect. Genet. Evol. 12, 557–564.
Coffey, L.L., and Vignuzzi, M. (2011). Host alternation of chikungunya virus in-
creases fitness while restricting population diversity and adaptability to novel
selective pressures. J. Virol. 85, 1025–1035.
Coffey, L.L., Forrester, N., Tsetsarkin, K., Vasilakis, N., and Weaver, S.C.
(2013). Factors shaping the adaptive landscape for arboviruses: implications
for the emergence of disease. Future Microbiol. 8, 155–176.
Couderc, T., Chre´tien, F., Schilte, C., Disson, O., Brigitte, M., Guivel-
Benhassine, F., Touret, Y., Barau, G., Cayet, N., Schuffenecker, I., et al.
(2008). Amousemodel for Chikungunya: young age and inefficient type-I inter-
feron signaling are risk factors for severe disease. PLoS Pathog. 4, e29.
Davis, C.T., Ebel, G.D., Lanciotti, R.S., Brault, A.C., Guzman, H., Siirin, M.,
Lambert, A., Parsons, R.E., Beasley, D.W.C., Novak, R.J., et al. (2005).
Phylogenetic analysis of North American West Nile virus isolates, 2001-
2004: evidence for the emergence of a dominant genotype. Virology 342,
252–265.
Domingo, E. (2010). Mechanisms of viral emergence. Vet. Res. 41, 38.
Emekli, U., Schneidman-Duhovny, D., Wolfson, H.J., Nussinov, R., and
Haliloglu, T. (2008). HingeProt: automated prediction of hinges in protein
structures. Proteins 70, 1219–1227.
Forrester, N.L., Guerbois, M., Seymour, R.L., Spratt, H., and Weaver, S.C.
(2012). Vector-borne transmission imposes a severe bottleneck on an RNA
virus population. PLoS Pathog. 8, e1002897.
Haliloglu, T., Bahar, I., and Erman, B. (1997). Gaussian dynamics of folded
proteins. Phys. Rev. Lett. 79, 3090–3093.
Herfst, S., Schrauwen, E.J.A., Linster, M., Chutinimitkul, S., de Wit, E.,
Munster, V.J., Sorrell, E.M., Bestebroer, T.M., Burke, D.F., Smith, D.J., et al.
(2012). Airborne transmission of influenza A/H5N1 virus between ferrets.
Science 336, 1534–1541.
Holmes, E.C. (2013). What can we predict about viral evolution and emer-
gence? Curr Opin Virol 3, 180–184.
Imai, M.,Watanabe, T., Hatta, M., Das, S.C., Ozawa, M., Shinya, K., Zhong, G.,
Hanson, A., Katsura, H., Watanabe, S., et al. (2012). Experimental adaptation
of an influenza H5 HA confers respiratory droplet transmission to a reassortant
H5 HA/H1N1 virus in ferrets. Nature 486, 420–428.
Kilpatrick, A.M. (2011). Globalization, land use, and the invasion of West Nile
virus. Science 334, 323–327.
Kilpatrick, A.M., Daszak, P., Goodman, S.J., Rogg, H., Kramer, L.D., Ceden˜o,
V., and Cunningham, A.A. (2006). Predicting pathogen introduction: West Nile
virus spread to Gala´ipagos. Conserv. Biol. 20, 1224–1231.716 Cell Host & Microbe 15, 706–716, June 11, 2014 ª2014 ElsevierKuno, G., and Chang, G.-J.J. (2005). Biological transmission of arboviruses:
reexamination of and new insights into components, mechanisms, and unique
traits as well as their evolutionary trends. Clin. Microbiol. Rev. 18, 608–637.
Lambrechts, L., Scott, T.W., and Gubler, D.J. (2010). Consequences of the ex-
panding global distribution of Aedes albopictus for dengue virus transmission.
PLoS Negl. Trop. Dis. 4, e646.
Le Flohic, G., Porphyre, V., Barbazan, P., and Gonzalez, J.P. (2013). Review of
climate, landscape, and viral genetics as drivers of the Japanese encephalitis
virus ecology. PLoS Negl. Trop. Dis. 7, e2208.
Li, H., and Durbin, R. (2009). Fast and accurate short read alignment with
Burrows-Wheeler transform. Bioinformatics 25, 1754–1760.
Li, H., Handsaker, B., Wysoker, A., Fennell, T., Ruan, J., Homer, N., Marth, G.,
Abecasis, G., and Durbin, R.; 1000 Genome Project Data Processing
Subgroup (2009). The Sequence Alignment/Map format and SAMtools.
Bioinformatics 25, 2078–2079.
Manimunda, S.P., Mavalankar, D., Bandyopadhyay, T., and Sugunan, A.P.
(2011). Chikungunya epidemic-related mortality. Epidemiol. Infect. 139,
1410–1412.
Ozden, S., Huerre, M., Riviere, J.-P., Coffey, L.L., Afonso, P.V., Mouly, V., de
Monredon, J., Roger, J.-C., El Amrani, M., Yvin, J.L., et al. (2007). Humanmus-
cle satellite cells as targets of Chikungunya virus infection. PLoS ONE 2, e527.
Pal, P., Dowd, K.A., Brien, J.D., Edeling, M.A., Gorlatov, S., Johnson, S., Lee,
I., Akahata, W., Nabel, G.J., Richter, M.K.S., et al. (2013). Development
of a highly protective combination monoclonal antibody therapy against
Chikungunya virus. PLoS Pathog. 9, e1003312.
Renault, P., Josseran, L., and Pierre, V. (2008). Chikungunya-related fatality
rates, Mauritius, India, and Reunion Island. Emerg. Infect. Dis. 14, 1327.
Schuffenecker, I., Iteman, I., Michault, A., Murri, S., Frangeul, L., Vaney, M.-C.,
Lavenir, R., Pardigon, N., Reynes, J.-M., Pettinelli, F., et al. (2006). Genome
microevolution of chikungunya viruses causing the Indian Ocean outbreak.
PLoS Med. 3, e263.
Tsetsarkin, K.A., and Weaver, S.C. (2011). Sequential adaptive mutations
enhance efficient vector switching by Chikungunya virus and its epidemic
emergence. PLoS Pathog. 7, e1002412.
Tsetsarkin, K.A., Vanlandingham, D.L., McGee, C.E., and Higgs, S. (2007). A
single mutation in chikungunya virus affects vector specificity and epidemic
potential. PLoS Pathog. 3, e201.
Tsetsarkin, K.A., Chen, R., Leal, G., Forrester, N., Higgs, S., Huang, J., and
Weaver, S.C. (2011). Chikungunya virus emergence is constrained in Asia by
lineage-specific adaptive landscapes. Proc. Natl. Acad. Sci. USA 108, 7872–
7877.
Vazeille, M., Moutailler, S., Coudrier, D., Rousseaux, C., Khun, H., Huerre, M.,
Thiria, J., Dehecq, J.-S., Fontenille, D., Schuffenecker, I., et al. (2007). Two
Chikungunya isolates from the outbreak of La Reunion (Indian Ocean) exhibit
different patterns of infection in the mosquito, Aedes albopictus. PLoS ONE 2,
e1168.
Voss, J.E., Vaney, M.-C., Duquerroy, S., Vonrhein, C., Girard-Blanc, C.,
Crublet, E., Thompson, A., Bricogne, G., and Rey, F.A. (2010). Glycoprotein
organization of Chikungunya virus particles revealed by X-ray crystallography.
Nature 468, 709–712.
Weaver, S.C., and Barrett, A.D.T. (2004). Transmission cycles, host range,
evolution and emergence of arboviral disease. Nat. Rev.Microbiol. 2, 789–801.
Ziegler, S.A., Lu, L., da Rosa, A.P.A.T., Xiao, S.-Y., and Tesh, R.B. (2008). An
animal model for studying the pathogenesis of chikungunya virus infection.
Am. J. Trop. Med. Hyg. 79, 133–139.Inc.
